In babies, the condition often shows up as firm, oily scales on the top and front of the scalp
With the emergence of grey-market sales, its clear that the demand for new solutions is high
Novo Nordisk filed for FDA approval of CagriSema in early 2026, with a review decision expected later this year
With the caveat that you'll gain a little bit back but not a huge amount." For its part, Calibrate says it has the interests of its patients at heart, and that it's acknowledging the fact that many of them are not going to stay on weight-loss drugs for life, given supply-chain shortages, insurance coverage limits, medication costs, issues with side effects, or them not wanting to stay on a medication forever
Koi Peptides Canada is not a licensed compounding pharmacy or a Drug Establishment Licence (DEL) holder under Health Canada's regulatory framework
FAQ Can I skip my semaglutide dose while I am on antibiotics